We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.14 | 2.10 | 2.18 | 2.20 | 2.19 | 2.19 | 604,698 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
TIDMIMM
RNS Number : 3521U
Immupharma PLC
29 July 2015
FOR IMMEDIATE RELEASE 29 JULY 2015
RICHARD WARR
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company is truly saddened to announce that Richard Warr, Chairman, passed away late last week.
Dimitri Dimitrou, Chief Executive Director said: "No words can truly convey the deep sadness we feel at Richard's untimely passing away. Richard will be remembered and missed by all of us at ImmuPharma. As a co-founder of ImmuPharma and a highly valued Chairman and friend, he provided the Board with insightful and considered advice and was instrumental in steering ImmuPharma into the successful Company we have today. All of us at ImmuPharma, associates and advisors who have worked closely with Richard over the years, extend our heartfelt thoughts and deepest sympathy to his wife and family."
ENDS
For further information please contact:
+ 44 (0) 20 7152 ImmuPharma plc 4080 Dimitri Dimitriou, Chief Executive Officer Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496 Panmure, Gordon & Co., NOMAD & Broker +44 (0) 20 7886 2500 Hugh Morgan Fred Walsh Duncan Monteith
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBUGDRBSDBGUI
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions